Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 5501  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
   Navigate here  
     Search
     Current Issue
     Submit Article 
     My Preferences 

Follow us on:

Twitter Icon Linkedin Icon Instagram Icon Facebook Icon

 


This article has been cited by
1Overlapping and distinct mechanisms of action of multiple sclerosis therapies
J.J. Graber,C.A. McGraw,D. Kimbrough,S. Dhib-Jalbut
Clinical Neurology and Neurosurgery.2010;112(7)583
[DOI]
2Early Mitoxantrone-Induced Cardiotoxicity Detected in Secondary Progressive Multiple Sclerosis
M.P. Namaka,D.A. Turcotte,M. Klowak,C.M. Leong,A. Grossberndt,J-A. Le Dorze,M.E. Prout,S. Andresen,L. Vuong,M.J. Melanson,E.E. Frost,M. Doupe
Clinical Medicine Insights: Therapeutics.2011;3(7)CMT.S7586
[DOI]
3Association between Appendectomy and Demyelinating Disorders in Subjects 40 Years and Older
HeanS Ooi,S Viswanathan,NeveinP Botross,GaikB Eow,YenT Chin,Ruban Kanesalingam,MohamedA R Isman,JiaM Cheang,RusliBin Nordin,Suneet Sood
Neurology India.2020;68(4)850
[DOI]
4Efficacy and tolerability of mitoxantrone for neuromyelitis optica spectrum disorder: A systematic review
Clare Angeli G. Enriquez,Adrian I. Espiritu,Paul Matthew D. Pasco
Journal of Neuroimmunology.2019;332(4)126
[DOI]
Online since 20th March '04
Published by Wolters Kluwer - Medknow